Trial Outcomes & Findings for Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy (NCT NCT03075176)

NCT ID: NCT03075176

Last Updated: 2023-07-17

Results Overview

Uncorrected visual acuity will be tested pre-operatively through month 12

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

39 participants

Primary outcome timeframe

12 months

Results posted on

2023-07-17

Participant Flow

39 participants were randomized, one participant withdrew, 38 completed wavefront surgery on one eye and topoguided surgery on the other eye. A total of 76 eyes were treated.

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
Wavefront Optimized LASIK
Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen). Wavefront optimized LASIK: Wavefront optimized laser vision correction Topography-guided LASIK: Topography-guided laser vision correction
Wavefront Optimized Photorefractive Keratectomy
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen). Wavefront optimized Photorefractive Keratectomy: Wavefront optimized laser vision correction Topography-guided Photorefractive Keratectomy: Topography-guided laser vision correction
Topography-guided LASIK
Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen). Wavefront optimized LASIK: Wavefront optimized laser vision correction Topography-guided LASIK: Topography-guided laser vision correction
Topography-guided Photorefractive Keratectomy
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen). Wavefront optimized Photorefractive Keratectomy: Wavefront optimized laser vision correction Topography-guided Photorefractive Keratectomy: Topography-guided laser vision correction
Overall Study
STARTED
18 18
20 20
18 18
20 20
Overall Study
COMPLETED
18 18
20 20
18 18
20 20
Overall Study
NOT COMPLETED
0 0
0 0
0 0
0 0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Wavefront Optimized LASIK
n=18 Eyes
Participants who chose to have LASIK surgery were assigned to have Wavefront optimized LASIK in one eye and Topography-guided LASIK in the other eye (randomly chosen). Wavefront optimized LASIK: Wavefront optimized laser vision correction Topography-guided LASIK: Topography-guided laser vision correction
Wavefront Optimized Photorefractive Keratectomy
n=20 Eyes
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Wavefront optimized Photorefractive Keratectomy in one eye and Topography-guided Photorefractive Keratectomy in the other eye (randomly chosen). Wavefront optimized Photorefractive Keratectomy: Wavefront optimized laser vision correction Topography-guided Photorefractive Keratectomy: Topography-guided laser vision correction
Topography-guided LASIK
n=18 Eyes
Participants who chose to have LASIK surgery were assigned to have Topography-guided LASIK in one eye and Wavefront optimized LASIK in the other eye (randomly chosen). Wavefront optimized LASIK: Wavefront optimized laser vision correction Topography-guided LASIK: Topography-guided laser vision correction
Topography-guided Photorefractive Keratectomy
n=20 Eyes
Participants who chose to have Photorefractive Keratectomy surgery were assigned to have Topography-guided Photorefractive Keratectomy in one eye and Wavefront optimized Photorefractive Keratectomy in the other eye (randomly chosen). Wavefront optimized Photorefractive Keratectomy: Wavefront optimized laser vision correction Topography-guided Photorefractive Keratectomy: Topography-guided laser vision correction
Total
n=76 Eyes
Total of all reporting groups
Age, Categorical
<=18 years
0 Eyes
n=18 Eyes
0 Eyes
n=20 Eyes
0 Eyes
n=18 Eyes
0 Eyes
n=20 Eyes
0 Eyes
n=76 Eyes
Age, Categorical
Between 18 and 65 years
18 Eyes
n=18 Eyes
20 Eyes
n=20 Eyes
18 Eyes
n=18 Eyes
20 Eyes
n=20 Eyes
76 Eyes
n=76 Eyes
Age, Categorical
>=65 years
0 Eyes
n=18 Eyes
0 Eyes
n=20 Eyes
0 Eyes
n=18 Eyes
0 Eyes
n=20 Eyes
0 Eyes
n=76 Eyes
Sex: Female, Male
Female
11 Eyes
n=18 Eyes
10 Eyes
n=20 Eyes
11 Eyes
n=18 Eyes
10 Eyes
n=20 Eyes
42 Eyes
n=76 Eyes
Sex: Female, Male
Male
7 Eyes
n=18 Eyes
10 Eyes
n=20 Eyes
7 Eyes
n=18 Eyes
10 Eyes
n=20 Eyes
34 Eyes
n=76 Eyes
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
18 Eyes
n=18 Eyes
20 Eyes
n=20 Eyes
18 Eyes
n=18 Eyes
20 Eyes
n=20 Eyes
76 Eyes
n=76 Eyes

PRIMARY outcome

Timeframe: 12 months

Population: Twelve month data was not collected for any participants. Because of the bias in who qualified for the study it became apparent we would not get any statistically valid results.

Uncorrected visual acuity will be tested pre-operatively through month 12

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 3 months

Population: Per 2018 protocol amendment contrast sensitivity assessment was removed from the study procedures and thus data was not collected.

Contrast sensitivity will be tested pre-operatively and 3 months post-operatively

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 3 months

Population: The Quality of Life Impact of Refractive Correction survey was removed from the protocol with the 2018 amendment, thus this data was not collected.

The validated Quality of Life Impact of Refractive Correction survey will be administered pre-operatively and 3 months post surgery

Outcome measures

Outcome data not reported

Adverse Events

Wavefront Optimized LASIK

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Wavefront Optimized Photorefractive Keratectomy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Topography-guided LASIK

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Topography-guided Photorefractive Keratectomy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Mark Mifflin, MD

University of Utah John A. Moran Eye Center

Phone: 801-213-4152

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place